Back to 
BLACKROCK ADVISORS LLC
BLACKROCK ADVISORS LLC
CYTKShowing 0 of 10 quarters
Position history for BLACKROCK ADVISORS LLC's holdings in CYTOKINETICS INC
As of its last 13F, for Q4 2016, BlackRock Advisors held 123,763 shares of CYTK (Cytokinetics), worth $1.5M. It increased the position by 948 shares (+0.8%) from Q3 2016. BlackRock Advisors held CYTK from Q3 2014 to Q4 2016, across 10 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of CYTK: BlackRock, Inc., BlackRock Finance, Inc., FMR LLC